Global ePRO, E-Patient Diaries and eCOA Markets Analysis Report 2023: Market to Reach $4.8 Billion by 2030 - COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO
Global Market for ePRO, E-Patient Diaries and eCOA
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "ePRO, E-Patient Diaries and eCOA: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global ePRO, E-Patient Diaries and eCOA Market to Reach $4.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 15% over the analysis period 2022-2030.
eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is projected to record a 15.3% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Epatient Reported Outcomes (epros) segment is readjusted to a revised 16.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $561.4 Million, While China is Forecast to Grow at 17.9% CAGR
The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$561.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$620.8 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.4% and 14.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.
Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New for 2023?
Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
No. of Pages
2022 - 2030
Estimated Market Value (USD) in 2022
Forecasted Market Value (USD) by 2030
Compound Annual Growth Rate
Key Topics Covered:
Impact of COVID-19 Pandemic and Looming Global Recession
Year 2021 in Review and Near-term Outlook
Pandemic Jolt Brings Strategic & Lasting Changes to Healthcare Sector
COVID-19 Expedites Healthcare Ecosystem's Evolution for Better Care & Cost Savings
The Adoption of Telemedicine Services Accelerates Amidst the Pandemic
Telemedicine Leads Digital Health Investments Driven by COVID-19
Pandemic Impact on eCOA, ePRO Market
COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO
eCOA Solutions Help Address Hurdles Due to COVID-19 Pandemic
eCOA Playing a Part in Development of COVID-19 Vaccine
An Introduction to ePRO, E-Patient Diaries and eCOA
Global Market Prospects & Outlook
eCOA: The Largest Category
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Recent Market Activity
MARKET TRENDS & DRIVERS
Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
Growing Demand for Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
Industry-Funded, Interventional Clinical Trial Study Starts for the Period 2015-2022E
Breakdown of Trial Starts by Therapeutic Area (2021)
COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
Global Venture Funding (in $ Million) in Digital Health Solutions Targeting Clinical Trials for 2015-2020
Trends in Clinical Trials to Influence Market Demand
Clinical Trials Increasingly Embraced Technology Amid COVID-19 Pandemic
Shift Towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
Global Virtual Clinical Trials Market Size (in US$ Billion) for the Years 2020, 2022, 2024 and 2026
Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
Growing Volumes of Data Generation in Decentralized Trials: A Challenge
Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
COVID-19 and Implications for Drug Development Regulations & Processes
Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
Rise in Telemedicine Services Present Market Opportunities
Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
Major Benefits of ePRO over Paper Form in Clinical Trials
Delivering Better Data: A Key Benefit of ePRO
Factors Ensuring Success ePRO Implementations
ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies
Key Technology Trends Impacting the ePRO in Clinical Trials
Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
Integrating AI Into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
Global e-COA Market by Delivery Mode (in %) for 2022E
eCOA Usage by Clinical Trial Phase (in %) for 2021
Technological Trends Transforming eCOA Solutions Market
Future Trends in eCOA Market: A Review
eCOA Proves Beneficial in Addressing Clinical Trial Challenges During COVID-19 Pandemic
UAT, Challenges and Embedded UAT for eCOAs
Benefits of BYOD for eCOAs
E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
Major Benefits of ePatient Diary
Increase in Healthcare Spending to Propel Demand
Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boosts Market
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Market Growth
FOCUS ON SELECT PLAYERS (Total 75 Featured)
Anju Software, Inc.
Climedo Health GmbH
Dassault Systemes SE
eClinical Solutions LLC
IQVIA Holdings, Inc.
Medidata Solutions Inc.
For more information about this report visit https://www.researchandmarkets.com/r/rhm198-e-patient?w=12
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900